Drug
Collagenase Clostridium Histolyticum
Collagenase Clostridium Histolyticum: highest development phase Phase 3, developed by Endo. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Endo
Trials
| Drug | Phase | Indication |
|---|---|---|
| collagenase clostridium histolyticum NCT00260429 | Phase 3 | Dupuytren's Disease |
| collagenase clostridium histolyticum NCT00528606 | Phase 3 | Dupuytren's Contracture |
Latest
No recent events.
Follow Collagenase Clostridium Histolyticum on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.